- Home
- DNTH vs HLIO Comparison
DNTH vs HLIO Comparison
Compare DNTH & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | HLIO |
|---|---|---|
| Founded | 2015 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DNTH | HLIO |
|---|---|---|
| Price | $45.90 | $64.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $68.88 | $52.40 |
| AVG Volume (30 Days) | ★ 811.5K | 290.5K |
| Earning Date | 03-10-2026 | 02-23-2026 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.01 |
| Revenue | $3,078,000.00 | ★ $807,700,000.00 |
| Revenue This Year | N/A | $4.43 |
| Revenue Next Year | N/A | $1.03 |
| P/E Ratio | ★ N/A | $63.40 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.37 | $24.76 |
| 52 Week High | $46.59 | $64.35 |
Technical Indicators
Market Signals| Indicator | DNTH | HLIO |
|---|---|---|
| Relative Strength Index (RSI) | 62.86 | 73.57 |
| Support Level | $42.37 | $60.23 |
| Resistance Level | $46.59 | $62.64 |
| Average True Range (ATR) | 2.79 | 2.26 |
| MACD | 0.67 | 0.75 |
| Stochastic Oscillator | 93.35 | 91.16 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.